|
Match
|
Document |
Document Title |
|
|
DE102019002677A1 |
Process for coating electrical or other technical equipment with a new type of warning signal substance
The present invention relates to a new substance and its special suitability for a method for coating cables, electrical or other technical devices with this warning signal substance in the event... |
|
|
DE102006012415B4 |
Enzymatic process for the production of degraded vegetable gum
A method for the recovery of degraded polygalactomannan, comprising the following steps: - Providing an aqueous solution of a polygalactomannan at a temperature which is in the range between 0 and... |
|
|
DE102018131131A1 |
Continuous process to obtain a crystalline monosaccharide
The invention relates to a continuous process for obtaining a crystalline monosaccharide, comprising a continuous crystallization of the monosaccharide in a main crystallizer (10), wherein in the... |
|
|
DE202011111124U1 |
Polymorph of a tretrasaccharide containing N-acetyllactosamine
A polymorph of Galpβ1-4GlcNAcpβ1-3Galpβl-4Glc (LNnT), characterized in that it has X-ray powder diffraction reflections based on a measurement using CuKa radiation, at a 2Θ angle of 20.32 ± 0.20,... |
|
|
DE202013012839U1 |
New polymorphs from LNnT
A crystalline LNnT polymorph IV, characterized in that it shows X-ray powder diffraction reflections based on a measurement using CuKa radiation at 2Θ angles of 8.16 and 15.41, more preferably at... |
|
|
DE202017007249U1 |
Separation of oligosaccharides from the fermentation broth
A solid sialylated oligosaccharide, the solid sialylated oligosaccharide being a spray dried or crystalline acidic human milk oligosaccharide selected from 6'-sialylylactose (6'-SL),... |
|
|
DE202017007248U1 |
Separation of oligosaccharides from the fermentation broth
A neutral human milk oligosaccharide containing N-acetylglucosamine, selected from LNT, LNnT or lacto-N-triose II, obtained by a process for separating a neutral oligosaccharide containing... |
|
|
DE102018007478A1 |
Medicinal or nutritional supplements for the treatment and / or prophylaxis of joint diseases and / or inflammatory joint diseases
Pharmaceutical or food supplements for the treatment and / or prophylaxis of diseases of the joints, especially arthrosis, which contain a collagen hydrolyzate in combination with free... |
|
|
DE202013012829U1 |
Improving the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or mixtures thereof
A spray-dried oligosaccharide from human milk (HMO) or a spray-dried HMO mixture with improved stability after prolonged storage at temperatures above 25 ° C and produced by a process comprising... |
|
|
DE202013012827U1 |
Improving the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or mixtures thereof
Spray-dried neutral oligosaccharide from human milk (HMO) or a spray-dried neutral HMO mixture with improved stability after prolonged storage at temperatures above 25 ° C., which is produced by a... |
|
|
DE202014011399U1 |
Neutral human milk oligosaccharides (HMOs) from microbial fermentation
A concentrate of a neutral human milk oligosaccharide (HMO) product containing a desired HMO in a concentration of ≥ 100 g / l and one or more impurities in an aqueous solution, the HMO product... |
|
|
DE202015009782U1 |
Separation of 2'-O-fucosyllactose from fermentation broth
Crystallized 2-O'-fucusyllactose (2'-FL) made by a process comprising the steps of: i. Culturing a genetically modified cell with a recombinant gene coding for a 1,2-fucosyltransferase and capable... |
|
|
DE202015009775U1 |
Separation of 2'-FL from a fermentation broth
Crystallized 2-O'-fucusyllactose (2'-FL) produced by a process comprising the following steps: i. Culturing a genetically modified cell containing a recombinant gene coding for a... |
|
|
DE102018116200A1 |
METHOD FOR PRODUCING A NUCLEOTIDE SUGAR
In a process for producing a monosaccharide-1-nucleoside diphosphate, a monosaccharide, a monosaccharide-1-phosphate kinase, a nucleoside triphosphate sugar-1-phosphate nucleosidyl transferase, a... |
|
|
DE102010034968B4 |
Polymerizable compounds and liquid-crystal media
Liquid-crystalline medium which comprises one or more compounds selected from the compounds of the formulas IA-1 to IA-10contains wherein R1' to R5' each independently of one another hydrogen,... |
|
|
DE102018201920A1 |
Liquid functionally improved isomalt
The present invention relates to a liquid isomalt composition comprising 6-O-alpha-D-glucopyranosyl-D-sorbitol (1,6-GPS) and 1-O-alpha-D-glucopyranosyl-D-mannitol (1,1-GPM ) and the other... |
|
|
DE102018201916A1 |
Solid functionally improved isomalt
The present invention relates to a solid isomalt composition comprising 6-O-alpha-D-glucopyranosyl-D-sorbitol (1,6-GPS) and 1-O-alpha-D-glucopyranosyl-D-mannitol (1,1-GPM ) and the other... |
|
|
DE102017010898A1 |
New inhibitors of shikimic acid pathway
The present invention relates to novel inhibitors of the shikimic acid pathway (shikimate route), to pharmaceutical compositions containing these novel inhibitors, to processes for the preparation... |
|
|
DE102017125888A1 |
New engineered T cell receptors and their use in immunotherapy
The present invention relates to antigen-recognizing constructs against COL6A3 antigens. In particular, the invention provides novel engineered T cell receptor (TCR) based molecules which are... |
|
|
DE102015219343B4 |
A method of processing seaweed-derived galactose using agarase
Process for preparing galactose, the process comprising: treating a residue of red algae by steps, comprising saccharification of the red algae by hydrolysis with an acid and filtration of the red... |
|
|
DE112017002818T5 |
Compound for use in an enzymatic reaction and mass spectrometry methods
A compound used in the conventional enzymatic reactions and mass spectrometry methods must be changed in structure as a substrate compound, such as the length of an alkyl chain contained therein,... |
|
|
DE102015214603B4 |
Phosphorus containing aminoglycoside salts
Compound of Formula 1 wherein the aminoglycoside is selected from the group of aminoglycoside or aminoglycoside group-containing antibiotics, where y is selected from 0.1 to 20, where n is... |
|
|
DE102017115966A1 |
Polypeptide molecule with improved dual specificity
The present invention relates to a bispecific polypeptide molecule, comprising a first polypeptide chain and a second polypeptide chain, which provide a binding region, derived from a T cell... |
|
|
DE112016005245T5 |
METHOD FOR THE FRACTIONATION OF LIGNOCELLULOSE-CONTAINING BIOMASS
This invention aims to develop a process for fractionating lignocellulosic biomass by contacting lignocellulosic biomass with treating liquid in a closed system at a temperature not exceeding 200... |
|
|
DE102017003004A1 |
Cationic polymers with D-fructose substituents
The invention relates to novel cationic polymers which are D-fructose conjugated, whereby they are able to interact selectively with specific structural elements on cell surfaces. The task was to... |
|
|
DE102017002810A1 |
Sialic acid derivatives with CC triple bond and their preparation
Sialic acid derivatives containing a CC triple bond are described, processes for their preparation, conjugates prepared therefrom and pharmaceutical compositions containing them. |
|
|
DE102017002252A1 |
Enzymatic process for the production of fructose
The present invention relates to a process for the preparation of aqueous solutions of D-fructose from a di-, oligo- or polysaccharide. Current methods are based on the generation of D-glucose... |
|
|
DE102007032799B4 |
Sugary metal complexes and their use
Sugar-containing metal complexes of substituted polypyridines of general formula I.(L1n)(L2m)(L3O)(L4p)(L5q)M+/-.consisting of ligands L1 to L5, wherein at least one of these ligands L1 to L5 is a... |
|
|
DE102006035020B4 |
Stabilization of NAD / NADH
A test element for the determination of an analyte comprising (i) a coenzyme dependent enzyme or a substrate for such an enzyme and (ii) as a coenzyme a compound having the following general... |
|
|
DE202015009594U1 |
New dimers of cytidine derivatives
A cytidine derivative dimer having the following general formula (I), wherein: R 1 is a CC alkyl, CC-substituted alkyl, - (CH) -Ph or substituted - (CH) -Ph; in - (CH) -Ph, n = 0, 1, 2, 3 ~ 10 and... |
|
|
DE102016225419A1 |
Olfactory signaling after overheating in technical facilities by pyrolysis of fragrance derivatives
The present invention relates to a method for providing a technical device with a warning signal against heating and a kit with which the method can be carried out. |
|
|
DE10113265B4 |
Use of a stabilized nucleic acid for the production of a protein
The invention teaches the use of a linear nucleic acid stabilized against exonuclease degradation in a method of producing a protein encoded by a base sequence of the nucleic acid in a cell-free... |
|
|
DE102016116121A1 |
Process for the epimerization of saccharides
The invention relates to a process for the epimerization of saccharides by heating a saccharide dissolved in a solvent in the presence of a metal-containing catalyst, an aldose being contacted... |
|
|
DE102016124844B3 |
DNA probes for in situ hybridization of chromosomes
Kit, probe mixtures and probes for the detection of a chromosome aberration. A gene probe obtained by a method comprising the following steps: (a) examining genomic sections for sequence regions... |
|
|
DE102011118022B4 |
Antibodies against the prostate-specific stem cell antigen and its use
The invention relates to recombinant antibodies that bind to prostate-specific stem cell antigen (PSCA). The antibody according to the invention contains complementarity-determining regions (CDR)... |
|
|
DE102007063902B3 |
Aptamers that bind to a target molecule involved in hemostasis
Aptamer that binds to a target molecule involved in hemostasis, the aptamer being an aptamer that binds to activated protein C, the aptamer having a dissociation constant KD binds to activated... |
|
|
DE102011018627B4 |
Modified nucleotides
Connection with structure (I): or a salt, a conjugate base, a tautomer or a dissociated form thereof, wherein P1 is a phosphate group; P2 is a phosphate group; Nus is a nucleoside structural unit... |
|
|
DE112012003416B4 |
Process for the preparation of 2- (4-methoxycarbonylpyrazol-1-yl) adenosine and 2- (4-ethoxycarbonylpyrazol-1-yl) adenosine
A process for the preparation of 2- (4-methoxycarbonylpyrazol-1-yl) adenosine of the formula Ia and 2- (4-ethoxycarbonylpyrazol-1-yl) adenosine of the formula Ib by reaction of... |
|
|
DE102015009439B4 |
Triple target HIV-1 NAT for the detection of all known genotypes
A primer / sample set for the detection of HIV, in particular HIV-1, comprising at least one primer / sample set 1 consisting of oligonucleotides comprising SEQ ID NOs 1, 2 and 3; Primer / sample... |
|
|
DE102006012414B4 |
Chemical process for the production of degraded polygalactomannans
A process for recovering degraded polygalactomannan comprising the steps of: providing a suspension of a polygalactomannan in an aqueous alcoholic solution having an alcohol concentration between... |
|
|
DE202017002052U1 |
Nucleoside pearl necklaces sequencing
An apparatus for DNA sequencing by passing a single-stranded DNA or RNA strand with anhybridized, chemically modified (nucleo-) bases, nucleosides or nucleotides by a biological or non-biological... |
|
|
DE102015219651A1 |
Compositions containing sugar amine and fatty acid
Compositions are described containing a) one or more sugar amines of the formula (I) wherein R1 and R2 are independently H, CH3 or 2-hydroxyethyl and / or one or more corresponding protonated... |
|
|
DE102007041476B4 |
Aptamers that bind to a target molecule involved in hemostasis
Aptamer that binds to a target molecule involved in hemostasis, the aptamer being a thrombin-binding fusion aptamer, comprising at least two thrombin-binding aptamers and at least one linker, the... |
|
|
DE202008018643U1 |
Nucleoside phosphoramidate drugs
Compound according to the following formula: in which (a) R1 Is hydrogen, methyl, ethyl, n-propyl, i-propyl or a substituted or unsubstituted phenyl, the substituent of the substituted phenyl... |
|
|
DE102015011780A1 |
New glutaminylcyclase inhibitors
The invention relates to a compound of the formula (I) for use as a glutaminylcyclase inhibitor, to a composition containing the compound for use as a QC inhibitor and to processes for the... |
|
|
DE102015214603A1 |
Phosphorus-containing aminoglycoside salts
The object is to provide aminoglycoside compounds which ensure a sustained release of aminoglycoside over clinically relevant periods in therapeutically effective concentrations. Aminoglycoside... |
|
|
DE112012003470B4 |
Process for the preparation of 2- [4 - [(methylamino) carbonyl] -1-H-pyrazol-1-yl] adenosine monohydrate
Process for the preparation of 2- [4 - [(methylamino) carbonyl] -1-H-pyrazol-1-yl] adenosine monohydrate of the formula I. comprising the steps: a) Allowing 2- (4-methoxycarbonylpyrazol-1-yl)... |
|
|
DE102015219343A1 |
A process for preparing galactose derived from marine algae using agarase
A method for preparing galactose by means of an enzymatic treatment of a red algal residue is provided. The process for preparing galactose comprises: preparing a residue; Treating the residue... |
|
|
DE102015008536A1 |
Discontinuous oligonucleotide ligands
The present invention relates to an oligonucleotide conjugate K of the structure or a pharmaceutically active salt thereof, wherein RNA1, RNA2, RNA3 and RNA4 are each strands of a ribonucleic acid... |
|
|
DE19549875B4 |
Use of magnetic particles to isolate nucleic acids
Magnetic particles with an outer glass surface that is essentially pore-free or has pores with a diameter of less than 10 nm and ferromagnetic particles with a glass surface can preferably be used... |